Institutional investment activity in BNY Mellon and Coherus Oncology
Picking up: 3 in the last 7 days
Updated sunday
The latest in this situation
- New institutional investors made purchases of BNY Mellon stock in November 2026.
- Multiple major financial institutions, including Renaissance Technologies and BlackRock, increased their holdings in Coherus Oncology stock on October 31, 2026.
- Major institutional investors, including BlackRock, Man Group, and BNY Mellon, acquired new stakes on October 31, 2026.
How it started
Institutional Investors Increase Stakes in Bank of New York Mellon
AI-generated briefing. Brind wrote this from the reports listed below and has updated it as the story developed. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Multiple institutional investors have recently increased their holdings in Bank of New York Mellon stock. Soltis Investment Advisors LLC boosted its shares by 113.5% during the third quarter, while BlackRock Inc. purchased a new stake in the second quarter valued at approximately $8.32 billion. Separately, CEO Robin Vince sold 40,620 shares of the bank’s stock on October 26th.
From themarketsdaily.com
Why it matters
The accumulation of shares by various large financial firms suggests significant institutional interest in the bank. Currently, 85.31% of the stock is owned by institutional investors and hedge funds.
From themarketsdaily.com
How it developed
Newest first. Tap a step to see who reported it.New institutional investors made purchases of BNY Mellon stock in November 2026.1 source
- Multiple major financial institutions, including Renaissance Technologies and BlackRock, increased their holdings in Coherus Oncology stock on October 31, 2026.Sub-event
Multiple firms made new purchases, but the target asset is not specified in the report.1 source